Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Medical University of Graz |
---|---|
Information provided by: | Medical University of Graz |
ClinicalTrials.gov Identifier: | NCT00463645 |
This is a mono-centre trial performed at the medical ICU at the Medical University Graz. There will be a study visit (V1) and a follow-up assessment (V2). In the study visit (V1) arterial blood glucose values will be monitored and subcutaneous sampling of interstitial fluid (ISF) with microdialysis for glucose determination and with microperfusion for cytokine-measurement will be performed. The study visit will last for 26 hours starting with the insertion of two catheters in the abdominal subcutaneous tissue (one microdialysis- and one microperfusion catheter). The primary hypothesis of the study is: Interstitial fluid glucose concentration profiles correlates to the arterial blood glucose concentration profile in patients with severe sepsis in the medical ICU.
Condition | Intervention |
---|---|
Severe Sepsis |
Procedure: microdialysis Procedure: microperfusion |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Official Title: | An Open, Mono-Centre Trial to Investigate the Correlation Between the Interstitial and Arterial Blood Concentrations of Glucose During Subcutaneous Glucose Monitoring in Patients With Severe Sepsis at the Medical Intensive Care Unit |
Ages Eligible for Study: | 18 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | CM3_adipose |
Study First Received: | April 19, 2007 |
Last Updated: | June 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00463645 |
Health Authority: | Austria: Ethikkommission |
Systemic Inflammatory Response Syndrome Sepsis Inflammation |
Pathologic Processes Infection |